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Abstract
Vertebrates evolved an endothelium-lined hemostatic system and a pump-driven pressurized circulation with a finely-
balanced coagulation cascade and elaborate blood pressure control over the past 500 million years. Genome analyses have
identified principal components of the ancestral coagulation system, however, how this complex trait was originally
regulated is largely unknown. Likewise, little is known about the roots of blood pressure control in vertebrates. Here we
studied three members of the serpin superfamily that interfere with procoagulant activity and blood pressure of lampreys, a
group of basal vertebrates. Angiotensinogen from these jawless fish was found to fulfill a dual role by operating as a highly
selective thrombin inhibitor that is activated by heparin-related glycosaminoglycans, and concurrently by serving as source
of effector peptides that activate type 1 angiotensin receptors. Lampreys, uniquely among vertebrates, thus use
angiotensinogen for interference with both coagulation and osmo- and pressure regulation. Heparin cofactor II from
lampreys, in contrast to its paralogue angiotensinogen, is preferentially activated by dermatan sulfate, suggesting that
these two serpins affect different facets of thrombin’s multiple roles. Lampreys also express a lineage-specific serpin with
anti-factor Xa activity, which demonstrates that another important procoagulant enzyme is under inhibitory control.
Comparative genomics suggests that orthologues of these three serpins were key components of the ancestral hemostatic
system. It appears that, early in vertebrate evolution, coagulation and osmo- and pressure regulation crosstalked through
antiproteolytically active angiotensinogen, a feature that was lost during vertebrate radiation, though in gnathostomes
interplay between these traits is effective.
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Introduction
Lampreys and hagfish are jawless fish whose ancestors diverged
from the other vertebrates more than 500 million years ago [1,2].
Modern lampreys have retained many features of early verte-
brates, although they also exhibit lineage-specific morphologic and
molecular traits [3,4]. Consequently, these animals serve as model
system for the study of complex features, such as vascular blood
coagulation or the endothelium-lined, pressurized circulatory
system that emerged at the rise of vertebrates [5]. Based primarily
on bioinformatic analyses of the lamprey genome, primordial
components of the vertebrate coagulation system have been
identified. The available evidence suggests that the multifactorial
cascade of procoagulant proteins, as it exists in gnathostomes,
evolved step-by-step from a simple set of clot-promoting factors
[6,7]. Thrombin and factor Xa (FXa), in particular, two key
coagulation enzymes, have been backtracked to the early
vertebrates. An ancestor of prothrombin can even be identified
in the chordate Branchiostoma [8,9]. However, how the first clot
promoting enzymes were regulated is not clear. Importantly,
antithrombin, the major inhibitor of thrombin and FXa in jawed
vertebrates, appears to be absent in lampreys [10,11]. In addition,
SERPINA10 (protein Z dependent protease inhibitor), another
serpin with anti-FXa activity [12,13], is missing, prompting
questions about how lampreys keep FXa activity in check and
how this procoagulant enzyme was initially regulated. First insights
into the role of serpins in early vertebrate physiology were
provided by the finding that lamprey angiotensinogen displays
potent heparin-accelerated anti-thrombin activity [14]. This is
unique among vertebrates, since all other orthologues are not
known to exert anti-proteolytic activity. The classical role of
angiotensinogen is that of a precursor protein for a family of
peptide hormones, the angiotensins. These hormones, among
others, modulate arterial blood pressure and extracellular fluid
osmolarity [15]. Angiotensin II, the best characterized member of
this peptide family, exerts its effects in mammals via G protein-
coupled receptors (GPCRs) [16]. The N-terminal end of
angiotensinogen from the European river lamprey, Lampetra
fluviatilis (L. fluviatilis), spans a 13 residue long sequence
(EEDYDERPYMQPF, hereafter lamprey angiotensin II) that
includes an octapeptide motif with 50% sequence identity (87.5%
similarity) to human angiotensin II. A cluster of five residues, not
found in any other orthologue, precedes the hormone motif in
lampreys [10,14]. Database searches and experimental approaches
further showed that lampreys possess a heparin cofactor II (HCII)
gene [10]. HCII is a serpin that acts as a specific and potent
thrombin inhibitor in the presence of dermatan sulfate or heparin
[17]. The interaction between HCII and its target involves
polyanion-mediated exposition of the inhibitor’s N-terminal tail
that enables binding to exosite I of thrombin, thus generating a
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reaction-enhancing additional contact interface between these
proteins [18]. Herein, we explore how the activities of procoag-
ulant enzymes in a primordial vertebrate are regulated. We also
investigate the role of lamprey angiotensinogen that combines
angiotensin II sequences with a serpin body active in protease
inhibition.
Materials and Methods
Materials
Human thrombin ($2 800 NIH U/ml), human plasmin,
human leukocyte cathepsin G, trypsin and a-chymotrypsin from
bovine pancreas, affinity-isolated anti-hemagglutinin (HA) anti-
bodies from rabbits and heparan sulfate from bovine kidney were
purchased from Sigma-Aldrich. Human FXa (176 IU/mg) was
from Enzyme Research Laboratories. Horse anti-mouse IgG and
Q5 high-fidelity DNA polymerase (2 000 U/ml) were from New
England BioLabs. Horseradish peroxidase-linked anti-rabbit
antibodies from donkey and IMAC Sepharose 6 Fast Flow were
purchased from GE Healthcare. The FXa substrate S-2222 was
from Chromogenix. PCR primers (Table S1) and codon-
optimized lamprey AGTR1 DNA fused to EGFP were obtained
from Life Technologies GmbH, Darmstadt, Germany. Tetra-
methylrhodamine-labeled lamprey angiotensin II (TMR-EEDY-
DERPYMQPF; TMR-angiotensin II for short) was delivered from
GenScript Inc., Piscataway, USA.
Site-directed Mutagenesis, PCR, cDNA Synthesis, and
DNA Sequencing
Site-directed mutagenesis was performed as delineated [19]. All
mutations were verified by sequencing. Standard PCR reactions
were performed with a Taq/Pfu (9:1) polymerase mix. G+C-rich
DNA fragments were amplified with Q5 high-fidelity DNA
polymerase using a modified SAFE-PCR protocol [20]. Reactions
(50 ml) including genomic DNA (typically 1 mg), 16Q5 reaction
buffer, 16Q5 high GC enhancer, primers (0.5 mM each) and
200 mM dNTPs each were set up and, after denaturation (5 min)
at 98uC, DNA polymerase (0.5 ml) was added. After six cycles that
included denaturation (30 s) at 98uC, annealing (40 s) with
stepwise reduction of temperature (62uCR56uC) and elongation
(2 min at 72uC), new enzyme was added, followed by another six
cycles under identical conditions. Finally, 30 further cycles (cycling
parameters: 30 s at 98uC, 40 s at 50uC, and 2 min at 72uC) were
carried out in the presence of fresh enzyme. Fragments of interest
were excised from gels and reamplified using Q5 high-fidelity
DNA polymerase. The subcloned fragments were sequenced with
the dGTP BigDye Terminator v3.0 Cycle Sequencing Ready
Reaction Kit (Applied Biosystems). Some G+C-rich segments were
sequenced by Seqlab Sequence Laboratories Go¨ttingen, Germany.
L. fluviatilis HCII cDNA was isolated using the GeneRacer cDNA
synthesis system as described [19]. The sequences of HCII cDNA
and the AGTR1 gene from L. fluviatilis have been deposited in
GenBank (accession numbers KF632587 and KF632588, respec-
tively).
Expression of Serpins and Lamprey AGTR1 in Mammalian
Cells
Transfection of COS7 cells with polyethylenimine (PEI) was
performed as outlined previously [21]. The lamprey angiotensin-
ogen expression construct contained the human angiotensin II
sequence in place of the original sequence thus enabling detection
with anti-human angiotensin II antibodies [14]. Lamprey HCII
expression was monitored through the HA tag attached to the N-
terminus of the protein. The sequences coding for the lamprey
AGTR1/EGFP chimera were assembled in pcDNA3.1. Trans-
fection of HEK293 cells was performed with PEI [22]. Cell lines
stably expressing the AGTR1/EGFP fusion protein were selected
with 400 mg/ml G418.
Expression, Refolding and Purification of Lfl_SpnV4_1
Residues 17 to 439 of Lfl_SpnV4_1 (GenBank accession:
FM991711.1) were fused, via a GT linker, to the N-terminal His6/
HA tag (sequence: MHHHHHHYPYDVPDYA), using pKM263
[23] as expression vehicle. The synthesis of the protein in E. coli
BL21(DE3) was induced by adding IPTG (final concentration:
0.5 mM) for 5 h at 30uC. The frozen cellular pellet of a 250 ml
culture was suspended in 15 ml of buffer A (20 mM Tris-HCl,
150 mM NaCl, pH 8.0). Cells were sonicated on ice (15 cycles,
1 min each, interrupted by 1 min intervals). After repeated
washing and centrifugation, the pellet was suspended in buffer A
containing 1% Triton X-100 and centrifuged. The inclusion
bodies were then incubated for 45 min at room temperature in
10 ml buffer C (20 mM Tris-HCl, 8 M urea, 150 mM NaCl,
pH 8.0) and spun down. The supernatant was adjusted with buffer
C to a protein concentration of about 1 mg/ml. For refolding, the
protein solution (6 ml) was diluted at room temperature into
250 ml RF buffer (50 mM Tris-HCl, 150 mM NaCl, 1 g/l PEG
8000, 10% (v/v) glycerol, 0.5 mM DTT and protease inhibitor
cocktail) over a period of 2 h under gentle stirring. Following
centrifugation and filtration, the supernatant (125 ml) was applied
to a Ni(II)-loaded 2-ml IMAC Sepharose 6 Fast Flow column
equilibrated with RF buffer. Following washing with RF buffer
containing 50 mM imidazole, bound material was eluted with
DTT-free RF buffer supplemented with 400 mM imidazole,
pH 8.0 and stored at 220uC until use.
Analysis of Serpin/Protease Complexes and Kinetics of
Serpin/Enzyme Reactions
Supernatants of serpin-producing COS7 cells were incubated
with enzymes at 25uC in the presence or absence of heparin,
heparan sulfate or dialyzed sodium nitrite-treated dermatan sulfate
for various times as indicated in the figure legends. Reactions were
terminated with 56Laemmli loading buffer. Complex formation
was assessed electrophoretically after heating (4 min at 95uC)
under reducing conditions followed by immunoblotting [21].
Second-order rate constants of the FXa/Lfl_SpnV4_1 interaction
were determined at 25uC by measuring cleavage of S-2222 at
Figure 1. Heparan sulfate enhances thrombin inhibition by
lamprey angiotensinogen with a bell-shaped dose-response
curve. Second order rate constants were measured as described under
Materials and Methods.
doi:10.1371/journal.pone.0097879.g001
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405 nm in 50 mM Tris-HCl, 130 mM NaCl, 1 g/l PEG 8000,
pH 8.3, in the presence or absence of heparin or Ca2+ ions, using a
10-fold molar inhibitor excess as outlined previously [21]. Human
FXa was titrated with antithrombin prior to determination of the
reaction stoichiometry [24]. The second order rate constant of
lamprey angiotensinogen mediated thrombin inhibition was
determined as described previously [14].
Confocal Microscopy
HEK293 cells expressing the lamprey AGTR1/EGFP chimera
were seeded in the Lab-Tek II Chambered #1.5 German
Coverglass System (8 wells) and cultured for 24 h at 37uC in
DMEM containing 10% FCS and 400 mg/ml G418. Untrans-
fected or empty vector- transfected cells were used as controls.
After preincubation (15 min) at 4uC in Earle’s buffer supplement-
ed with 0.1% BSA and 0.01% glucose, TMR-angiotensin II was
added (final concentration: 50 nM). After 30 min at 4uC, the
temperature was raised to 37uC for 5 or 30 min, respectively. The
Figure 2. Anti-thrombin activity of lamprey HCII in the presence of various GAGs. Supernatants from COS7 cells expressing HA-tagged
HCII from L. fluviatilis were incubated with human thrombin either in the absence of cofactors or in the presence of 50 U/ml heparin, 50 mg/ml
heparan sulfate, or 400 mg/ml dermatan sulfate. Complex formation was monitored with antibodies directed against the HA-tag attached to the N-
terminus of the lamprey serpin. The sizes of marker proteins are shown on the left. c, no thrombin added, TC: thrombin/HCII complex.
doi:10.1371/journal.pone.0097879.g002
Figure 3. Formation of SDS-stable complexes following
exposure of FXa to Lfl_SpnV4_1. Refolded Lfl_SpnV4_1 was
incubated for 60 min in the absence (lane 1) or for 1, 2, 3, 4 or 5 min
in the presence of human FXa (lanes 2 to 5). Lfl_SpnV4_1 and its
complexes with the protease were detected by immunoblotting, using
antibodies recognizing the HA-tag attached to the N-terminal end of
the serpin.
doi:10.1371/journal.pone.0097879.g003
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cells were then rinsed with PBS and fixed for 60 min at room
temperature in 4% PBS buffered formaldehyde. Cells were
examined with a Zeiss LSM780 inverted confocal microscope
equipped with an argon laser. EGFP fluorescence was detected in
a window between 493–554 nm after excitation at 488 nm.
Double fluorescence detection was performed at 493–554 nm
(EGFP) and 566–685 nm (TMR-angiotensin II), following excita-
tion at 488 nm and 561 nm, respectively. Images of cells
(102461024 pixels) were obtained using a 636oil immersion
objective.
Bioinformatic Analyses and Protein Modelling
Genomic sequences of P. marinus, accessible at the Ensembl
Genome Browser (Pmarinus_7.0, Ensembl release 71) [25] were
queried with BLASTP, using human AGTR1 for search.
Sequences coding for the lamprey PI4KA gene were identified
accordingly. The exon-intron structure of the P. marinus HCII gene
was deduced by comparing the sea lamprey genomic sequence
with the cDNA of the L. fluviatilis orthologue. The genomic DNA
sequences coding for Lfl_SpnV4_1 was deposited previously in
GenBank (accession: FM991712). AGTR sequences were aligned
with Clustal Omega and phylogenetic analyses were performed
using the Neighbor-Joining methodology as implemented in
MEGA5 [26] with 1 000 bootstrap replicates. Tree construction
was based on the following GPCR proteins (GenBank accession
numbers in brackets): AGTR1 sequences: Homo sapiens
(NP_114438.2), Rattus norvegicus (P25095.1; P29089.1),Mus musculus
(P29754.1; P29755.1), Oryctolagus cuniculus (P34976.1), Bos taurus
(P25104.1), Ovis aries (O77590.2), Sus scrofa (P30555.1), Gallus gallus
(P79785.1), Bufo marinus (BAF48111.1), Danio rerio (CAQ15007.1),
Anguilla anguilla (CAB40835.1), Scyliorhinus canicula (cat shark)
(CAF02299.1), Dasyatis sabina (Atlantic stingray) (ADO64259.1);
AGTR2 sequences: Homo sapiens (NP_000677.2), Rattus norvegicus
(AAB34021.1), Mus musculus (AAB29336.1), Bos taurus
(DAA13460.1), Meriones unguiculatus (Mongolian gerbil)
(Q9Z0Z6.1), Oryctolagus cuniculus (NP_001076107.1), Canis familiaris
(ABA40750.1), Xenopus laevis (NP_001072452.1). Opsin from
Drosophila melanogaster (AAA28733.1) was used as outgroup.
Results
Angiotensinogen and HCII from Lampreys are Highly
Selective Thrombin Inhibitors
Lamprey angiotensinogen rapidly reacts with human thrombin
when activated by heparin, which demonstrates that the serpin
may serve as effective protease inhibitor in this agnathan fish [14].
In order to explore the anti-proteolytic spectrum of this protein,
we examined a panel of additional proteases for their ability to
interact with the inhibitor, using the complex formation assay.
However, none of the enzymes tested, including FXa, plasmin,
and cathepsin G from humans or trypsin and chymotrypsin from
bovine formed a complex with the lamprey protein. Angiotensin-
ogen from this jawless fish is thus a highly selective thrombin
inhibitor. Since it is not clear whether lampreys produce heparin-
containing proteoglycans, we also investigated the effects of
heparan sulfate, a glycosaminoglycan (GAG) widespread in
metazoans. Figure 1 indicates that heparan sulfate, at 100 mg/
ml, enhances thrombin inhibition about 360-fold with a bell-
shaped dose-response curve. Though heparan sulfate is less
effective than heparin (860-fold rate enhancement), it is distinctly
superior to the 9-fold stimulation obtained with dermatan sulfate
[14]. We also investigated the properties of HA-tagged lamprey
HCII secreted from transfected COS7 cells. The recombinant
protein formed a complex with human thrombin and both
dermatan sulfate and heparin strongly enhanced the reaction.
Heparan sulfate also stimulated complex formation, although to a
lesser extent (Figure 2). No complexes were detected with human
FXa. We conclude that angiotensinogen and HCII from lampreys
are both potent and highly selective thrombin inhibitors in the
presence of appropriate cofactors, however, they are stimulated
differently by GAGs.
Lampreys Contain a Serpin with Anti-FXa Activity
We next explored whether lampreys that seemingly do not
produce antithrombin, are equipped with a FXa inhibiting serpin.
From the nine lamprey serpin genes currently known, we chose
the previously identified Lfl_SpnV4_1 gene from L. fluviatilis [10]
for further investigation. The gene encodes a protein of 439 amino
acids, including a predicted N-terminal secretion signal. Similar to
the canonical mammalian FXa inhibitors, antithrombin and
SERPINA10, Lfl_SpnV4_1 has an Arg residue at the presumed
P1 position of its reactive site–loop (RSL) (TEE-
GAEAAAVTGVFLSRTNPIYPVFKVDRPF). Expression of N-
terminally HA-tagged Lfl_SpnV4_1 in COS7 cells led to secretion
of a 66 kDa protein capable of forming SDS stable complexes
(about 83 kDa) with human FXa. Concomitantly, cleaved
inhibitor molecules appeared (Figure 3). Low amounts of
complexes were also detected after extended incubation with
bovine trypsin. All other enzymes examined, including thrombin
and plasmin, did not react in this assay (not shown), indicating that
human FXa is a preferred target of Lfl_SpnV4_1. In order to
characterize the anti-FXa activity of the protein further, the
Figure 4. Conserved microsynteny of the genes coding for HCII and PI4KA. In lampreys and man, the HCII gene is located, in antiparallel
orientation, within an intron of the PI4KA gene. The PI4KA gene of lampreys harbors another intron-located gene in close proximity to HCII, termed
SpnV4_1. This gene codes for a serpin that inhibits human FXa. In humans and other vertebrates, only the HCII gene has been retained. The genomic
arrangement was extracted from the P. marinus genome as accessible at the Ensembl Genome Browser (Pmarinus_7.0, release 71, accession:
ENSPMAG00000008040). The exon-intron structure of the HCII gene was modified, using the L. fluviatilis cDNA sequence as a basis. Exons are
represented as filled boxes.
doi:10.1371/journal.pone.0097879.g004
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inhibitor was expressed in E. coli and purified. Following refolding,
the kinetic parameters of the inhibitor/enzyme reaction were
determined. The second order rate constant k2 was determined to
be 7.76106 M21 min21, and the stoichiometry of inhibition (SI)
was 1.9. Addition of heparin (50 U/ml) increased the reaction rate
constant about 3.5 fold, while inclusion of 2.5 mM Ca2+ did not
significantly affect k2.
Interestingly, the genes coding for HCII and SpnV4_1 are
located in close proximity within an intron of the phosphatidy-
linositol 4-kinase a (PI4KA) gene, both in the genomes of the sea
lamprey, Petromyzon marinus (P. marinus) (Figure 4) and in L.
fluviatilis (not shown). The synteny of the HCII and PI4KA genes is
preserved in humans and other vertebrates, which enables facile
identification of HCII across vertebrates and demonstrates the
ancestral nature of this genomic arrangement. SpnV4_1 ortholo-
gues are not detected in currently annotated gnathostomes,
suggesting that the gene was lost in this lineage.
Figure 5. Phylogenetic analysis of AGTR proteins. Sequence relationships were inferred using the Neighbor-Joining method. The numbers at
the branch points indicate the percentage of 1000 bootstrap replicates supporting the receptor classification. GenBank accession numbers of protein
sequences are given in Materials and Methods.
doi:10.1371/journal.pone.0097879.g005
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Lampreys Possess a Functional Angiotensin II/Type 1-like
Angiotensin Receptor (AGTR1) Signaling Axis
In order to explore the potential of lamprey angiotensin II to
serve as effector peptide, we searched for appropriate receptors.
Inspection of the sea lamprey genome revealed a corrupted
sequence (Ensembl accession: ENSPMAG00000005736) sharing
about 40% identity (60% similarity) to human AGTR1. Using
degenerate primers we isolated an apparently complete gene
coding for a GPCR protein from genomic L. fluviatilis DNA. The
sequence, containing segments with up to 85% G+C, encodes a
protein of 352 residues sharing about 94% identity with the P.
marinus orthologue. Phylogenetic analyses assort the protein to the
AGTR1 family albeit with moderate bootstrap support (Figure 5).
Sequence alignments indicate that the lamprey protein contains
several motifs associated with AGTR1 functionality [27–29],
including a DRY motif vital for G protein coupling and a C-
terminal Ser/Thr-rich sequence required for internalization and
desensitization of the membrane protein. Compellingly, several
residues critically important for angiotensin II binding or ligand-
mediated activation of mammalian AGTR1, including D74,
N111, W253, D281, and Y292 (numbering refers to the human
receptor) are conserved or replaced by conservative amino acid
substitution (residue 199) in lampreys. Position 292, suggested to
discriminate between AGTR1 and AGTR2 sequences [30] is
occupied by Tyr (as opposed to Phe) in the lamprey protein, in
accord with its classification as AGTR1 family member (Figure
S1).
To verify whether ligand binding results in receptor activation,
we expressed a lamprey AGTR1/EGFP chimera in HEK293
cells. Figure 6 shows that the fusion protein is associated
primarily with the plasma membrane as revealed by the green
fluorescence of the reporter. Addition of 50 nM TMR-angiotensin
II resulted in rapid association of the ligand with the cell surface.
Untransfected control cells did not show ligand accumulation at
the membrane, indicating that binding of the lamprey peptide to
cells was due to interaction with the receptor chimera. Rapid
formation of ligand/receptor clusters at the cell surface was
followed by internalization. Punctate intracellular structures
harboring both TMR-labeled ligand and the EGFP-tagged
receptor were evident within 30 min. We thus conclude that
lampreys own an AGTR1-like protein that is activated by the
appropriate ligand.
Discussion
Our investigations address the roles of serpins as regulators of
procoagulant enzymes and providers of effector peptides in a
Figure 6. Internalization of EGFP-tagged lamprey AGTR1 transfected into HEK293 cells upon exposure to TMR-angiotensin II.
HEK293 cells stably expressing the lamprey AGTR1/EGFP fusion protein were stimulated with 50 nM TMR-angiotensin II at 37uC. The confocal images
show the subcellular distribution of receptors (green) and the ligands (red) 5 and 30 min after ligand addition. Note the colocalization of ligands and
receptors close to the plasma membrane early after stimulation and in punctate structures in the cytoplasm after prolonged incubation (merged
images). The scale bar corresponds to 5 mm.
doi:10.1371/journal.pone.0097879.g006
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jawless fish, and their implications ensuing for coagulation control
and pressure modulation in the ancestors of vertebrates. The
occurrence of HCII and angiotensinogen, both in lampreys and in
gnathostomes, documents persistence of these serpins over more
than 500 million years. Likewise, colocalization of HCII and
SpnV4_1 in the lamprey genome is consistent with the ancient
nature of the latter gene. These serpins thus were supposedly
involved in the regulation of the early procoagulant cascade as
indicated by their biochemical activities. In gnathostomes, only
one of these proteins, HCII, has survived functionally unchanged
since ancient times. The biochemical parameters identify
Lfl_SpnV4_1 as a fairly potent and selective inhibitor of human
FXa. It appears that SpnV4_1 was lost along gnathostome
radiation; however, its survival in lampreys provides insight into
the early history of vertebrate serpins. Genomic colocalization of
paralogues often results from local duplication events involving
unequal crossing over [31]. The close proximity of the HCII and
Lfl_SpnV4_1 genes within an intron of the lamprey PI4KA gene
adds support for the gene structure-based classification of
vertebrate serpins in six groups (V1–V6). This classification
implies that group V2, of which HCII is a member, and group
V4, to which Lfl_SpnV4_1 belongs, are closely related [32].
Lamprey angiotensinogen, surprisingly, is a third serpin with
anticoagulant activity. Heparin and heparan sulfate potently
stimulate the thrombin/inhibitor reaction with a bell-shaped dose
dependence, presumably because these GAGs provide a scaffold
enabling ternary complex formation similar to that observed
during heparin/thrombin/antithrombin interaction [33].
Integrating bioinformatic data on procoagulant lamprey pro-
teins [11,34] and experimental analysis of the anti-proteolytic
activities of their serpin counterparts enables reconstruction of the
protein network that may have constituted the haemostatic system
of primordial vertebrates (Figure 7). HCII and angiotensinogen
are ancestral thrombin inhibitors that were supposedly engaged in
distinct aspects of thrombin physiology, as indicated by their
preference of different GAGs. With respect to cofactor quality,
angiotensinogen from lampreys resembles antithrombin, while
HCII prefers dermatan sulfate similar to HCII in mammals.
Lfl_SpnV4_1 appears to be a vestige of a serpin lineage that
regulated FXa activity. Together, this serpin triad may have
fulfilled the tasks that, in gnathostomes, are performed mainly by
the broad-spectrum inhibitor antithrombin.
Thrombin from lampreys and mammals shares important
structural features that govern the enzyme’s selective interaction
with cofactors, macromolecular substrates and inhibitors, includ-
ing the 60-loop, the anion binding exosites I and II, and the
sodium loop [9,35]. These shared structural features explain the
specific interaction of HCII and angiotensinogen from lampreys
with the human enzyme. Conservation of RSL sequences and the
hirudin like N-terminal tail of HCII across vertebrates [10], and
the RSL sequence similarity between lamprey angiotensinogen
and vertebrate HCII also reflect conservation of the reciprocal
dependence of the protease and its inhibitors for productive
interaction.
Several lines of evidence show that lampreys have a functional
angiotensin II/AGTR1 signaling axis. Firstly, lamprey angioten-
sinogen exhibits an N-terminal sequence that is highly similar to
mammalian angiotensin II. All the essential residues for angio-
tensin II/AGTR1 interaction and receptor activation in mammals
(i.e. positions 2, 4, 6, and 8 in DRVYIHPF) are either fully
preserved or replaced by conservative substitutions in lampreys
(ERPYMQPF). Secondly, the lamprey GPCR identified here
groups phylogenetically with the vertebrate AGTR1 family, and
several residues important for receptor activation and signal
transduction in mammals are preserved in the lamprey protein.
Thirdly, exposure of HEK293 cells expressing lamprey AGTR1 to
lamprey angiotensin II results in endocytosis and formation of
intracellular punctate structures containing both ligand and
receptor. Receptor internalization is triggered by ligand concen-
trations comparable to those in mammals and with similar kinetics
Figure 7. Serpins and their roles in blood coagulation of early vertebrates. Angiotensinogen, HCII and an SpnV4_1-like serpin are proposed
as principal regulators of the primordial procoagulant system (A). The ancestral clotting cascade presumed to be present in the last common ancestor
of jawless fish and gnathostomes is based on the scheme suggested by Doolittle [11]. The coagulation scheme of mammals and its serpin inhibitors
are shown for comparison (B).
doi:10.1371/journal.pone.0097879.g007
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[36]. Fourthly, injection of lamprey angiotensin II at 100–
1000 pmol/kg provokes a cardiovascular response in cannulated
conscious lampreys [37]. Blood pressure, however, is transiently
decreased by the peptide, pointing to differences in pressure
control mechanisms of lampreys and mammals.
Though we have uncovered a functional angiotensin II/
AGTR1 system in lampreys, several questions remain unresolved.
The enzymatic machinery liberating angiotensin peptides from its
precursor in lampreys is unknown. The standard path of
angiotensinogen processing in mammals involves the activity of
the aspartyl protease renin that releases the decapeptide angio-
tensin I from the N-terminus. Subsequently, angiotensin convert-
ing enzyme 1 (ACE1) generates angiotensin II by clipping off two
C-terminal amino acids. The P. marinus genome does not clearly
show a renin orthologue, however an ACE1 gene (Ensembl
accession: ENSPMAG00000007309) appears to be present in
lampreys. It remains to be seen whether alternative routes of
angiotensin liberation [38] and/or as yet unknown processing
alleys are active in lampreys.
Lampreys are as yet the earliest diverged metazoans with a
functional angiotensin II/AGTR1 axis, however it is not clear,
when this axis was first assembled. Angiotensin-like sequences
were identified in some leeches (Theromyzon tessulatum, Erpobdella
octoculata), but in a non-serpin context [39]. Related species, such
as Helobdella robusta, however, do not seem to possess angiotensin-
related sequences. DNA transfer may explain these observations,
potentially favored by the long persistence of foreign DNA in
parasitic leeches [40]. Uptake of genetic material harboring
angiotensin sequences may have happened in other metazoans as
well, including early vertebrates, with subsequent conservation
along this lineage, using the serpin backbone as a carrier. It is also
possible that these hormone sequences are ancestral and were lost
in some lineages. ACE homologues are present in insects [39], but
these enzymes may also cleave other substrates.
Our findings also shed light on the interlinkage of blood
coagulation and pressure regulation in the ancestral endothelium-
lined circulatory system of vertebrates. It appears that this lineage,
early in evolution, has developed a set of serpins capable to
antagonize the procoagulatory cascade concomitantly with pres-
sure regulation. Though this link was subsequently uncoupled in
gnathostomes, the connections between these traits in this lineage
are strong. Various constituents of the coagulation system may
affect, in vitro and in vivo, the vascular tone in mammals [41].
Thrombin, for instance, may participate in tone regulation [42,43]
and HCII promotes NO bioavailability in humans [44] and may
activate the eNOS signaling pathway [45]. In mammals, clotting
and pressure regulation are interdigitated through multiple ties,
including endothelin and bradykinin. The roots of these inter-
lockings, however are largely unknown.
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